Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Mangoceuticals, Inc. ( (MGRX) ) is now available.
On April 24, 2025, Mangoceuticals, Inc. entered into an Intellectual Property Purchase Agreement with Smokeless Technology Corp., acquiring intellectual property related to oral pouches for nutritional and wellness products. This strategic move allows Mangoceuticals to expand into the fast-growing oral pouch market, leveraging Smokeless Tech’s stimulant formulations to enhance their existing product lines. Additionally, the company appointed Tim Corkum, a former executive at JUUL Labs Canada, to lead the development of this new product division. These developments are expected to significantly bolster Mangoceuticals’ market positioning and growth potential in the nutraceutical sector.
More about Mangoceuticals, Inc.
Mangoceuticals, Inc. is a company focused on developing, marketing, and selling a variety of health and wellness products through a secure telemedicine platform under the brands MangoRx and PeachesRx. The company primarily targets the growing sectors of erectile dysfunction, hair growth, hormone replacement therapies, and weight management for men and women.
YTD Price Performance: -15.66%
Average Trading Volume: 204,822
Technical Sentiment Signal: Buy
Current Market Cap: $13.12M
See more data about MGRX stock on TipRanks’ Stock Analysis page.